Introduction
============

Volume-assured pressure support is a feature on bi-level positive airway pressure support (BPAP) machines that deliver a consistent preset target volume by automatically adjusting the inspiratory pressure support within a set range. Therefore, varying pressure requirements in different sleep stages can be provided.

We present a case of a patient in whom the volume-assured pressure support feature was effective in managing nocturnal respiratory failure.

Case Report
===========

Our patient is a 3-year-old girl with multiminicore myopathy (a recessively inherited congenital myopathy).

At 7 months old she was noted to have axial weakness, gross motor delay, and poor weight gain. She had frequent lower respiratory tract infections and required antibiotics, oxygen, and chest physiotherapy.

She was referred to the Sydney Children\'s Hospital (SCH) Neuromuscular Clinic due to her significant weakness and respiratory issues at 12 months old. The diagnosis was confirmed by electromyography and muscle biopsy. She had a weak cough, poor secretion clearance, gastro-esophageal reflux, and probable recurrent aspiration pneumonia. She was started on nasogastric feeds and then a percutaneous endoscopic gastrostomy tube was inserted. She was referred to the SCH Department of Sleep Medicine at 24 months old on the basis of her diagnosis and possibility of nocturnal hypoventilation.

Following review, a routine overnight polysomnogram (PSG) was organized and this was carried out at the age of 31 months using the Compumedics Grael system (Melbourne, Australia). Oxygen saturation was \<92% for 25% of the study and there were frequent desaturations to a nadir of 72%. In REM sleep, there were multiple episodes of poor respiratory effort, desaturation, and CO~2~ retention (TcCO~2~ range 50--72 mmHg). The apnea--hypopnea index was 12.2 per hour mainly due to central hypopneas.

BPAP was initiated with a BiPAP Harmony machine (Philips Respironics, Murrysville, PA, USA) with settings of inspiratory positive airway pressure (IPAP) 10 cm H~2~O, expiratory positive airway pressure (EPAP) 4 cm H~2~O, and respiratory rate (RR) 25 per minute in the spontaneous timed (ST) mode. A Maskmedic Paediatric Concept™ (Maskmedic Pty Ltd, Balmain, NSW, Australia) size 2 nasal mask was used.

A BPAP titration study was carried out with these settings. There were still significant desaturations and CO~2~ retention to a maximum TcCO~2~ of 92 mmHg despite increasing the IPAP and EPAP to 20 and 6 cm H~2~O, respectively. The patient triggered all breaths and synchronized well with the machine. There were significant differences in ventilatory requirements in different sleep stages. The final settings were ST mode, IPAP 20 cm H~2~O, EPAP 6 cm H~2~O, RR 22 per minute, and inspiratory time 1 sec.

Five days later, she had another BPAP titration study with the Philips Respironics Trilogy machine with average volume-assured pressure support (AVAPS) in the ST mode. The targeted tidal volume (TV) was 80 mL (8 mL/kg). The EPAP was fixed at 4 cm H~2~O. The minimum IPAP (IPAP~min~) was 11 cm H~2~O. The initial maximum IPAP (IPAP~max~) was 15 cm H~2~O. There was good synchrony. The IPAP~max~ was increased to achieve the target TV as this was not carried out with an IPAP of 15 cm H~2~O. TcCO~2~ ranged from 54 to 67 mmHg. The lowest oxygen saturation was 86%. In NREM sleep, the IPAP required to reach the TV was 13--15 cm H~2~O and in REM sleep 16--17 cm H~2~O.

The final settings were EPAP 4 cm H~2~O, IPAP~min~ 11 cm H~2~O, IPAP~max~ 17 cm H~2~O, AVAPS on with target TV of 80 mL, AVAPS rate of change of 2 cm H~2~O/minute, RR 22 per minute, and inspiratory time 1 sec (see Table [1](#tbl1){ref-type="table"}).

###### 

PSG parameters and BPAP settings

                          Sleep efficiency (%)   AHI (/h)   Baseline SaO~2~ (%)   SaO~2~ nadir (%)   CO~2~ range (mmHg)   Final settings
  ----------------------- ---------------------- ---------- --------------------- ------------------ -------------------- -------------------
  Diagnostic study        93                     12.1       97                    72                 54--74               
  Conventional BPAP       82                     0          99                    77                 58--92               IPAP: 20 cm H~2~O
  EPAP: 6 cm H~2~O                                                                                                        
  Rate: 22 bpm                                                                                                            
  Mode: S/T                                                                                                               
  BPAP with AVAPS         72.9                   0          99                    88                 50--66               Target TV: 80 mL
  IPAP min: 8 cm H~2~O                                                                                                    
  IPAP max: 17 cm H~2~O                                                                                                   
  EPAP: 4 cm H~2~O                                                                                                        
  Rate: 20 bpm                                                                                                            
  Mode: S/T with AVAPS                                                                                                    

AHI, apnea hypopnea index; AVAPS, average volume-assured pressure support; BPAP, bi-level positive airway pressure support; EPAP, expiratory positive airway pressure; IPAP, inspiratory positive airway pressure; PSG, polysomnogram; TV, tidal volume.

She was reviewed 2 months later. She was tolerating the airway support well. She had not had further episodes of pneumonia and was more active and alert. Her compliance was 98% with average daily use of 5.5 h. The low usage was most likely due to humidification issues and improved with correction of humidification. Machine download showed that she had varied IPAPs to achieve her preset TV with an IPAP~max~ of 17 cm H~2~O at some point each sleep (range was 11--17 cm H~2~O; see Fig. [1](#fig01){ref-type="fig"}).
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Discussion
==========

Many patients (especially those with neuromuscular disorders) have varying pressure requirements in different stages of sleep. The volume-assured pressure support feature allows the BPAP machine to adjust the IPAP to achieve a set TV. This means that patients can be managed with lower pressures for most of the night but with increased pressures when needed. This then improves comfort, compliance, and ventilation [@b1], [@b2].

There have been some small studies looking at volume-assured pressure support in adults. The patient groups were adults with obesity hypoventilation syndrome and chronic obstructive pulmonary disease (COPD). Improved sleep quality and normalization of TcCO~2~ with volume-assured pressure support was shown, but possibly with a decrease in sleep efficiency 1--3. The volume-assured pressure support feature has been shown to be beneficial in acute respiratory failure in patients with COPD and hypercapnic encephalopathy [@b4]. There are almost no studies of volume-assured pressure support in children. There is one case report of a teenager with congenital central hypoventilation syndrome who was successfully transitioned from ventilation via tracheostomy to non-invasive ventilation -- BPAP with AVAPS [@b5]. In PSGs performed following initiation, she had normal sleep architecture with normal oxygen saturations and TcCO~2~.

This case highlights the potential benefits of BPAP with volume-assured pressure support such as AVAPS in managing nocturnal hypoventilation in pediatric neuromuscular disorders with possible extension to other conditions requiring nocturnal ventilatory support. As most studies to date have been carried out in adults with different diseases to children, further studies looking at the volume-assured pressure support feature in children is warranted.
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